**3. Conclusions**

The high number of articles published in this Special Issue entitled "Paediatric Formulation: Design and Development" highlights the significant amount of research being conducted on the development of medicines designed for paediatric patients.

Formulating an appropriate dosage form is a challenge when considering chronic diseases that affect children and minimizing the dose frequency. Key aspects in paediatric formulations involve the design and development of novel dosage forms, which should be adjustable for age, palatable, easy to administer, and, at the same time, safer and e ffective.

**Author Contributions:** Writing—original draft preparation; writing—review and editing; visualization; supervision, A.L. and N.D. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Acknowledgments:** We would like to thank all the authors who submitted their work for this Special Issue. Particular thanks also to all of the reviewers who participated and enhanced the quality of the articles by seeking clarification for arguments and requesting modifications where necessary.

**Conflicts of Interest:** The authors declare no conflict of interest.
